UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044537 |
|---|---|
| Receipt number | R000050882 |
| Scientific Title | Development of educational tools for improving hand hygiene behavior using virtual reality (VR) technology |
| Date of disclosure of the study information | 2021/08/01 |
| Last modified on | 2021/06/15 05:40:18 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Development of educational tools for improving hand hygiene behavior using virtual reality (VR) technology
Acronym
Development of educational tools for improving hand hygiene behavior using virtual reality (VR) technology
Scientific Title
Development of educational tools for improving hand hygiene behavior using virtual reality (VR) technology
Scientific Title:Acronym
Development of educational tools for improving hand hygiene behavior using virtual reality (VR) technology
Region
| Japan |
Condition
Condition
not applicable
Classification by specialty
| Infectious disease | Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the effectiveness of VR developed to promote hand hygiene behavior.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Hand hygiene implementation rate in WHO 5 moments
Key secondary outcomes
Consumption of portable alcohol gel
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Single blind -investigator(s) and assessor(s) are blinded
Control
Placebo
Stratification
NO
Dynamic allocation
NO
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
Educational experience through VR contents
Interventions/Control_2
Conventional lectures
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 70 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Students in Okayama University or medical professionals affiliated with Okayama University Hospital
Key exclusion criteria
Those who are aware of germophobia and filthophobia
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Hideharu |
| Middle name | |
| Last name | Hagiya |
Organization
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Division name
Department of General Medicine
Zip code
700-0086
Address
2-5-1 Shikata, Okayama
TEL
086-235-7342
hagiya@okayama-u.ac.jp
Public contact
Name of contact person
| 1st name | Hideharu |
| Middle name | |
| Last name | Hagiya |
Organization
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Division name
Department of General Medicine
Zip code
700-0086
Address
2-5-1, Shikata, Okayama
TEL
086-235-7342
Homepage URL
hagiya@okayama-u.ac.jp
Sponsor or person
Institute
Okayama University
Institute
Department
Personal name
Funding Source
Organization
Okayama University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee
Address
2-5-1, Shikata, Okayama
Tel
086-235-6938
mae6605@adm.okayama-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
岡山大学病院（岡山県）
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 08 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2021 | Year | 07 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2021 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2022 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2021 | Year | 06 | Month | 15 | Day |
Last modified on
| 2021 | Year | 06 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050882
